Assessing vitamin C for vertigoRadical scavengers for Ménière's disease after failure of conventional therapy: a pilot study.
We investigated the effectiveness of several radical scavengers, including vitamin C, to manage symptoms of Ménière's disease (MD), particularly focusing on vertigo. In our pilot study, we administered rebamipide, vitamin C at a dose of 600 mg daily, and glutathione to 25 patients who had difficulty controlling their MD symptoms.
After at least eight weeks of treatment, we observed noteworthy improvements among our participants. Specifically, 21 out of 22 patients experienced considerable relief from vertigo, while improvements in hearing disorders and tinnitus were reported in a subset of ears. Ultimately, this suggests that vitamin C, alongside other treatments, may play a role in alleviating vertigo symptoms.
While we cannot isolate the specific impact of vitamin C due to its combination with other treatments, these findings highlight the potential of radical scavengers like vitamin C in managing the often debilitating effects of Ménière's disease.
Read More
Iron treatment alleviates vertigo symptomsSymptom panorama in upper secondary school students and symptoms related to iron deficiency. Screening with laboratory tests, questionnaire and interventional treatment with iron.
Our study aimed to understand how iron deficiency impacts students' experiences, particularly focusing on symptoms like vertigo and dizziness. We set out to identify undiagnosed iron deficiency among first-grade students at an upper secondary school and evaluated changes in their symptoms and lab results after three months of iron supplementation.
Through our research, we found that 12% of the students had iron deficiency, and 61% exhibited some abnormal test results related to iron levels. Notably, we observed that symptoms of vertigo and dizziness were significantly more common in those with iron deficiency. After the students received iron supplementation, we recorded notable improvements: iron levels increased, transferrin levels decreased, and importantly, there was a marked reduction in symptoms, including vertigo, irritability, and depressive feelings.
Our findings convincingly highlight that iron supplementation can be beneficial in alleviating certain symptoms, specifically vertigo and dizziness, among students struggling with iron deficiency. This connection opens doors to addressing quality of life issues tied to iron levels among young individuals.
Read More
Vitamin C and vertigo connectionsChange of extracellular ascorbic acid in the brain cortex following ice water vestibular stimulation: an on-line electrochemical detection coupled with in vivo microdialysis sampling.
We investigated how ascorbic acid (vitamin C) impacts vertigo by observing changes in its levels in the brain during specific vestibular stimulation. Our study involved sixteen guinea pigs, divided into three groups to explore the effects of different temperatures of water on their ear canals.
The experimental group was exposed to ice water, while two control groups received warm water and ice water to an auricle, respectively. Through a method called microdialysis, we monitored the concentration of ascorbic acid in the primary sensory area of the brain after caloric vestibular stimulation.
Remarkably, we found that the extracellular levels of ascorbic acid increased significantly in response to the ice water stimulation. This finding sheds light on the potential neurochemical roles of vitamin C during episodes of vertigo. While this study does not isolate vitamin C as a standalone treatment, it opens intriguing avenues for future research on its therapeutic potential in vertigo-associated conditions.
Read More
Ascovertin shows promise for vertigo[Clinical efficacy of a novel hemorheological drug ascovertin in patients with vascular encephalopathy].
We examined the effectiveness of ascovertin, a blend of dihydroquercetin and vitamin C, in treating patients with stages I and II of vascular encephalopathy, especially focusing on its impact on vertigo. The study included 21 patients aged 45 to 65 who received ascovertin over a span of 21 days.
Participants reported significant improvements in headaches, reduction in vertigo, and enhanced mental clarity. Notably, the treatment led to a marked decrease in whole blood viscosity, which is a measure of blood flow and can affect overall brain health.
Despite the positive outcomes, it's important to highlight that we cannot clearly separate the effects of vitamin C from those of dihydroquercetin. Therefore, while ascovertin appears to help with vertigo, we cannot definitively say how much vitamin C alone contributes to these benefits.
Read More